Researcher profile · Semantic Scholar

Abbie E. Fearon

h-index: 6
Works: 10
Citations: 276

Most-cited papers

Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.
Edward P. Carter, Abbie E. Fearon, R. Grose
2015Trends in Cell Biology133 citations
Semantic Scholar
FGFR signalling in women's cancers.
Abbie E. Fearon, Charlotte R. Gould, R. Grose
2013International Journal of Biochemistry and Cell Biology65 citations
Semantic Scholar
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer
Abbie E. Fearon, Edward P. Carter, N. Clayton, E. Wilkes +15 more
2018Cell Reports48 citations Open access
Semantic Scholar
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosis
Abbie E. Fearon, C. Slabber, A. Kuklin, Marc Bachofner +7 more
2021iScience12 citations Open access
Semantic Scholar
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction
N. Clayton, Edward P. Carter, Abbie E. Fearon, J. Heward +5 more
2023International Journal of Molecular Sciences8 citations Open access
Semantic Scholar
Grb-ing receptor activation by the tail
Abbie E. Fearon, R. Grose
2014Nature Structural &Molecular Biology8 citations
Semantic Scholar
The FGFR Receptor Family
Abbie E. Fearon, A. Chioni, R. Grose
20152 citations
Semantic Scholar
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer
Abbie E. Fearon, Edward P. Carter, N. Clayton, E. Wilkes +15 more
2026Cell Reports0 citations
Semantic Scholar
Dissection of drug resistance mechanisms in FGFR2 mutant endometrial cancer.
Abbie E. Fearon
20150 citations
Semantic Scholar
Abstract 4266: Investigating the functional effects of oncogenic FGFR2 mutations in endometrial cancer.
Abbie E. Fearon, P. Cutillas, R. Grose
20130 citations
Semantic Scholar

E. Wilkes

×3

Ekaterina Kapitonova×2

Yasmine Tanner×2

E. Gadaleta×2

C. Chelala×2

K. Moore×2

John F. Marshall×2

J. Chupin×2